Korean Idiopathic Pulmonary Fibrosis Registry

Last updated: November 8, 2019
Sponsor: Seoul National University Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Cystic Fibrosis

Lung Disease

Scar Tissue

Treatment

N/A

Clinical Study ID

NCT04160715
1.1
  • Ages 30-100
  • All Genders

Study Summary

This is a multicenter prospective registry of IPF patients in South Korea. The Seoul National University Bundang Hospital is the coordination center for the Korean IPF Registry built by a collaboration of the Korean Interstitial Lung Diseases (ILD) Study Group.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • IPF patients diagnosed by multidisciplinary discussion

Exclusion

Exclusion Criteria:

  • Other interstitial lung diseases except for IPF

  • connective tissue disease-related ILD

  • exposure-related ILD

Study Design

Total Participants: 3000
Study Start date:
January 01, 2016
Estimated Completion Date:
December 31, 2026

Study Description

Korean ILD Study Group includes investigators of 30 hospitals. Demographic, pulmonary function, laboratory data, chest CT findings and hospital course of IPF patients are collected.

Connect with a study center

  • Seoul National University Bundang Hospital

    Seongnam-si, 13620
    Korea, Republic of

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.